Bull&Bear | Herbalife, Pulmonx, and Unity Surge While Editas and Materialise Plummet
In the stock market's bullish sector, Herbalife (HLF) shares surged by 42.70%. This increase comes as Mizuho Securities maintains a hold rating for the company.
Pulmonx (LUNG) saw a significant rise of 32.23% as its stock price surged after exceeding expectations in its fourth-quarter earnings report.
Unity Software (U) experienced a 30.41% increase, with William Blair maintaining a buy rating for the company. This reflects growing optimism around Unity's market performance.
Tuya Inc. (TUYA) went up by 26.80%, continuing a three-day rally totaling a 30.20% increase. Tuya's announcement to integrate deep search artificial intelligence into its pet technology segment and partnership with DeepSeek is being seen as a move to redefine the future of pet care with multimodal AI.
Origin Materials (ORGN) increased by 24.76% after the company announced its continued progress in commercial qualification and revealed the production of bottle caps with new functionalities.
Conversely, in the bearish segment, Editas Medicine (EDIT) faced a substantial drop of 35.63%. Bank of America continues to uphold a sell rating for the company, setting a target price of $1.
Materialise (MTLS) dropped by 35.36%, marking a three-day downturn amounting to a 38.05% decline. The company’s ADR was negatively impacted by industrial headwinds in Europe, which led to a deterioration in their fourth-quarter performance and 2025 outlook.
Jumia Technologies (JMIA) saw a 27.32% decrease over four days, cumulatively declining 32.21%. This drop was attributed to the company's disappointing fourth-quarter financial results, which were below market expectations.
Trupanion (TRUP) fell by 25.49%, marking a three-day downtrend totaling 28.67%. This decline occurred amid a broader slump in U.S. small-cap stocks, where Trupanion was notably affected.
TFI International (TFII) experienced a 20.48% decline after being downgraded by Bank of America, as the company potentially faces challenging first-quarter conditions deemed "poor."


Comentarios
Aún no hay comentarios